Colorectal cancer
Conditions
Interventions
CIT group:CIK combined chemotherapy
SLAMF7+:IHC SLAMF7 Score 2-3
SLAMF7-:IHC SLAMF7 Score 0-1
Sponsors
Yan'an Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
39 Years to 87 Years
Inclusion criteria
Inclusion criteria: 1.Patients who underwent radical resection, pathologically confirmed primary colorectal adenocarcinoma; 2.Aged 18-80 years; 3.without chemotherapy or radiotherapy preoperative; 4.without severe autoimmune disease or immunodeficiency disease; 5.without infectious diseases syphilis or AIDS,without active hepatitis B or C; 6.cardiovascular, liver, kidney, coagulation functions are normal; 7.without other malignant tumors; 8.case data and information were complete.
Exclusion criteria
Exclusion criteria: 1.Combined with severe cardiovascular, liver, kidney disease or disfunction; 2.combined with other malignancies; 3.combined with autoimmune disease; 4.combined with syphilis or HIV infection; 5.combined with pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival;Progress-Free Survival;SLAMF7 IHC score; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum tumor marker; | — |
Countries
China
Contacts
Public ContactRuhong Li
Yan'an Affiliated Hospital of Kunming Medical University
Outcome results
None listed